跳至主要内容
临床试验/CTRI/2024/02/062688
CTRI/2024/02/062688招募中4 期

Prospective, single arm, post-marketing clinical study of EYECRYL™PLUS (600) intraocular lens to assess performance and safety in patientsundergoing cataract surgery. - NI

Biotech vision care pvt ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age 18 year or greater
  • 2. Cataract
  • 3. Calculated IOL power is within the range of the
  • investigational IOL.
  • 4. Clear intraocular media other than cataract
  • 5. Patient willing to participate and sign informed consent to
  • participate in study and to use device related data for
  • scientific purpose
  • 6. Patient willing to come for all post-operative follow-up
  • 7. Female participants of child bearing potential and male
  • participants whose partner is of child bearing potential must
  • be willing to ensure that they or their partner use effective
  • contraception during the study.

排除标准

  • 1. Previous intraocular or corneal surgery
  • 2. Traumatic cataract
  • 3. Pregnancy
  • 5. Vulnerable subject.
  • 6. Patients receiving chloroquine treatment.
  • 7. Patient having Microphthalmia.
  • 8. Patient having Chronic Uveitis.
  • 9. Patient suffering from corneal dystrophy or endothelial
  • insufficiency.
  • 10. Patient having active ocular diseases (active diabetic
  • retinopathy, uncontrolled glaucoma

研究者

发起方
Biotech vision care pvt ltd

相似试验